Becton Dickinson - Medical Technology and Life Sciences Specialist Benefits from Recovery Effects!
Reading Time: 1 minute
Business Driver: The US pharmaceutical and life sciences specialist Becton Dickinson (BDX) can benefit from the prospect of a recovery in demand due to rising treatment and patient numbers. Recently, they significantly strengthened their position by acquiring the Critical Care division from Edward Life Sciences, enhancing their portfolio in the area of connected care and monitoring solutions as well as AI tools that assist doctors and healthcare professionals with important questions regarding diagnosis, treatment, and patient care. On November...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
